Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$84.07
0.650.78%
À la fermeture: -
$84.07
0.000.00%
Après les heures de négociation: Aug 29, 4:31 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Colgate-Palmolive Co a un objectif de cours consensus de $100.37, basé sur les évaluations des 20 analystes. Le plus élevé est de $110 attribué par B of A Securities le juillet 10, 2024, et le plus bas est de $83 attribué par Wells Fargo le août 4, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Citigroup, JP Morgan et Morgan Stanley le août 4, 2025. Avec un objectif de cours moyen de $98.67 entre Citigroup, JP Morgan et Morgan Stanley, il y a une variation implicite de 17.36% upside pour Colgate-Palmolive Co à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Citigroup
JP Morgan
Morgan Stanley
Wells Fargo
UBS
1calculé à partir des notes des analystes
Notes d'analystes pour Colgate-Palmolive
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/04/2025 | 24.9% | Citigroup | $108 → $105 | Maintains | Buy | |||
08/04/2025 | 13% | JP Morgan | $99 → $95 | Maintains | Overweight | |||
08/04/2025 | 14.19% | Morgan Stanley | $104 → $96 | Maintains | Overweight | |||
08/04/2025 | -1.27% | Wells Fargo | $88 → $83 | Maintains | Underweight | |||
07/25/2025 | 17.76% | JP Morgan | $103 → $99 | Maintains | Overweight | |||
07/17/2025 | 26.09% | UBS | $109 → $106 | Maintains | Buy | |||
07/15/2025 | 3.49% | Barclays | $86 → $87 | Maintains | Equal-Weight | |||
04/28/2025 | 28.46% | Citigroup | $103 → $108 | Maintains | Buy | |||
04/28/2025 | 22.52% | JP Morgan | $95 → $103 | Maintains | Overweight | |||
04/17/2025 | 29.65% | UBS | $105 → $109 | Maintains | Buy | |||
04/11/2025 | 2.3% | Barclays | $89 → $86 | Maintains | Equal-Weight | |||
04/11/2025 | 13% | JP Morgan | $99 → $95 | Maintains | Overweight | |||
04/02/2025 | 4.67% | Wells Fargo | $83 → $88 | Maintains | Underweight | |||
03/31/2025 | 27.27% | Piper Sandler | $108 → $107 | Maintains | Overweight | |||
03/27/2025 | 5.86% | Barclays | $83 → $89 | Maintains | Equal-Weight | |||
03/14/2025 | 17.76% | JP Morgan | $97 → $99 | Maintains | Overweight | |||
02/03/2025 | 15.38% | JP Morgan | $103 → $97 | Maintains | Overweight | |||
02/03/2025 | 18.95% | UBS | $104 → $100 | Maintains | Buy | |||
02/03/2025 | 10.62% | Stifel | $95 → $93 | Maintains | Hold | |||
02/03/2025 | 16.57% | RBC Capital | $101 → $98 | Maintains | Sector Perform | |||
02/03/2025 | 24.9% | Raymond James | $110 → $105 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 23.71% | Morgan Stanley | $111 → $104 | Maintains | Overweight | |||
01/29/2025 | 20.14% | RBC Capital | $101 → $101 | Reiterates | Sector Perform → Sector Perform | |||
01/17/2025 | 13% | Stifel | $101 → $95 | Maintains | Hold | |||
01/17/2025 | -1.27% | Barclays | $96 → $83 | Maintains | Equal-Weight | |||
01/16/2025 | 23.71% | UBS | $112 → $104 | Maintains | Buy | |||
01/16/2025 | 22.52% | JP Morgan | $109 → $103 | Maintains | Overweight | |||
01/08/2025 | 18.95% | TD Cowen | $110 → $100 | Maintains | Buy | |||
01/07/2025 | -1.27% | Wells Fargo | $92 → $83 | Maintains | Underweight | |||
01/06/2025 | 33.22% | Piper Sandler | $121 → $112 | Maintains | Overweight | |||
10/28/2024 | 9.43% | Wells Fargo | $100 → $92 | Maintains | Underweight | |||
10/28/2024 | 30.84% | TD Cowen | $115 → $110 | Maintains | Buy | |||
10/28/2024 | 20.14% | Stifel | $105 → $101 | Downgrade | Buy → Hold | |||
10/11/2024 | 35.6% | JP Morgan | $113 → $114 | Maintains | Overweight | |||
09/24/2024 | 43.93% | Piper Sandler | → $121 | Initiates | → Overweight | |||
09/16/2024 | 18.95% | Wells Fargo | → $100 | Downgrade | Equal-Weight → Underweight | |||
09/09/2024 | 29.65% | Deutsche Bank | $107 → $109 | Downgrade | Buy → Hold | |||
09/04/2024 | 45.12% | UBS | $119 → $122 | Maintains | Buy | |||
07/30/2024 | 36.79% | TD Cowen | $110 → $115 | Maintains | Buy | |||
07/30/2024 | 22.52% | Bernstein | $100 → $103 | Maintains | Market Perform | |||
07/29/2024 | 27.27% | Deutsche Bank | $104 → $107 | Maintains | Buy | |||
07/29/2024 | 32.03% | Morgan Stanley | $103 → $111 | Maintains | Overweight | |||
07/29/2024 | 14.19% | Barclays | $91 → $96 | Maintains | Equal-Weight | |||
07/26/2024 | — | HSBC | — | Downgrade | Buy → Hold | |||
07/24/2024 | 13% | Jefferies | $103 → $95 | Downgrade | Buy → Hold | |||
07/23/2024 | 30.84% | TD Cowen | → $110 | Initiates | → Buy | |||
07/22/2024 | 24.9% | Stifel | $95 → $105 | Maintains | Buy | |||
07/19/2024 | 8.24% | Barclays | $85 → $91 | Maintains | Equal-Weight | |||
07/18/2024 | 26.09% | Evercore ISI Group | $100 → $106 | Maintains | Outperform | |||
07/17/2024 | 23.71% | Deutsche Bank | $98 → $104 | Maintains | Buy | |||
07/10/2024 | 33.22% | Citigroup | $103 → $112 | Maintains | Buy | |||
07/10/2024 | 30.84% | B of A Securities | $100 → $110 | Maintains | Buy | |||
07/10/2024 | 15.38% | Wells Fargo | $92 → $97 | Maintains | Equal-Weight | |||
06/24/2024 | 29.65% | Exane BNP Paribas | → $109 | Initiates | → Outperform | |||
05/28/2024 | 22.52% | Morgan Stanley | $101 → $103 | Maintains | Overweight | |||
05/15/2024 | 27.27% | Argus Research | $97 → $107 | Maintains | Buy | |||
04/30/2024 | 1.11% | Barclays | $84 → $85 | Maintains | Equal-Weight | |||
04/29/2024 | 9.43% | Wells Fargo | $90 → $92 | Maintains | Equal-Weight | |||
04/29/2024 | 13% | Stifel | $94 → $95 | Maintains | Buy | |||
04/29/2024 | 18.95% | B of A Securities | $90 → $100 | Maintains | Buy | |||
04/29/2024 | 13% | RBC Capital | $88 → $95 | Maintains | Sector Perform | |||
04/16/2024 | 18.95% | Citigroup | $95 → $100 | Maintains | Buy | |||
04/12/2024 | -0.08% | Barclays | $82 → $84 | Maintains | Equal-Weight | |||
04/10/2024 | 11.81% | Stifel | $89 → $94 | Maintains | Buy | |||
04/08/2024 | 14.19% | Evercore ISI Group | $90 → $96 | Maintains | Outperform | |||
03/01/2024 | 10.62% | Goldman Sachs | → $93 | Reinstates | → Buy | |||
01/29/2024 | 10.62% | Morgan Stanley | $85 → $93 | Maintains | Overweight | |||
01/29/2024 | 13% | UBS | $93 → $95 | Maintains | Buy | |||
01/29/2024 | 4.67% | Wells Fargo | $80 → $88 | Maintains | Equal-Weight | |||
01/29/2024 | 8.24% | Raymond James | → $91 | Upgrade | Market Perform → Outperform | |||
01/18/2024 | 7.05% | JP Morgan | $88 → $90 | Maintains | Overweight | |||
01/16/2024 | -2.46% | Barclays | $75 → $82 | Maintains | Equal-Weight | |||
12/15/2023 | 7.05% | B of A Securities | → $90 | Upgrade | Neutral → Buy | |||
11/29/2023 | 4.67% | JP Morgan | $83 → $88 | Maintains | Overweight | |||
11/13/2023 | 3.49% | Jefferies | → $87 | Initiates | → Buy | |||
10/30/2023 | -4.84% | RBC Capital | $79 → $80 | Maintains | Sector Perform | |||
10/30/2023 | 1.11% | Morgan Stanley | $89 → $85 | Maintains | Overweight | |||
10/17/2023 | -10.79% | B of A Securities | $85 → $75 | Maintains | Neutral | |||
10/16/2023 | -3.65% | Stifel | $85 → $81 | Upgrade | Hold → Buy | |||
10/12/2023 | -13.17% | Barclays | $81 → $73 | Maintains | Equal-Weight | |||
10/12/2023 | -3.65% | JP Morgan | $85 → $81 | Maintains | Overweight | |||
10/11/2023 | 1.11% | Citigroup | $92 → $85 | Maintains | Buy | |||
09/22/2023 | -0.08% | HSBC | → $84 | Initiates | → Buy | |||
08/01/2023 | -3.65% | Barclays | $77 → $81 | Maintains | Equal-Weight | |||
07/31/2023 | -1.27% | RBC Capital | → $83 | Reiterates | Sector Perform → Sector Perform | |||
07/31/2023 | 8.24% | Deutsche Bank | $88 → $91 | Maintains | Buy | |||
05/01/2023 | 1.11% | B of A Securities | $80 → $85 | Maintains | Neutral | |||
05/01/2023 | 8.24% | Evercore ISI Group | $85 → $91 | Maintains | Outperform | |||
05/01/2023 | -1.27% | RBC Capital | $82 → $83 | Maintains | Sector Perform | |||
05/01/2023 | 14.19% | Goldman Sachs | $86 → $96 | Maintains | Buy | |||
05/01/2023 | 5.86% | Morgan Stanley | $82 → $89 | Maintains | Overweight | |||
05/01/2023 | -3.65% | Wells Fargo | $76 → $81 | Maintains | Equal-Weight | |||
05/01/2023 | 9.43% | Citigroup | $88 → $92 | Maintains | Buy | |||
03/29/2023 | 2.3% | UBS | $84 → $86 | Maintains | Buy | |||
03/20/2023 | -4.84% | Deutsche Bank | $84 → $80 | Maintains | Buy | |||
02/17/2023 | -0.08% | Citigroup | → $84 | Initiates | → Buy | |||
01/31/2023 | -8.41% | Barclays | $80 → $77 | Maintains | Equal-Weight | |||
01/30/2023 | -9.6% | Wells Fargo | $80 → $76 | Maintains | Equal-Weight | |||
01/30/2023 | -2.46% | Morgan Stanley | → $82 | Upgrade | Equal-Weight → Overweight | |||
01/13/2023 | 2.3% | JP Morgan | $81 → $86 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action Colgate-Palmolive (CL) ?
Le dernier objectif de prix pour Colgate-Palmolive (NYSE:CL) a été rapporté par Citigroup le août 4, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $105.00 s'attendant à ce que CL se rise dans les 12 prochains mois (un possible changement de 24.90% upside). 38 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Colgate-Palmolive (CL) ?
La dernière note d'analyste pour Colgate-Palmolive (NYSE:CL) a été fournie par Citigroup, et Colgate-Palmolive maintenu leur note buy.
Quand a eu lieu la dernière mise à niveau pour Colgate-Palmolive (CL) ?
La dernière amélioration pour Colgate-Palmolive Co a eu lieu le janvier 29, 2024 lorsque Raymond James a augmenté leur objectif de prix à $91. Raymond James avait précédemment a market perform pour Colgate-Palmolive Co.
Quand a eu lieu la dernière dégradation pour Colgate-Palmolive (CL) ?
La dernière réduction pour Colgate-Palmolive Co a eu lieu le octobre 28, 2024 lorsque Stifel a changé leur objectif de prix de $105 à $101 pour Colgate-Palmolive Co.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Colgate-Palmolive (CL) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Colgate-Palmolive, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Colgate-Palmolive a été déposée le août 4, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers août 4, 2026.
La note d'analyste pour Colgate-Palmolive (CL) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Colgate-Palmolive (CL) était un maintenu avec un objectif de prix de $108.00 à $105.00. Le prix actuel de Colgate-Palmolive (CL) est de $84.07, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.